NRC
LLY icon

New Republic Capital’s Eli Lilly LLY Stock Holding History

New Republic Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.6M Buy
3,001
+1,358
+83% +$1.39M 0.83% 23
2026
Q1 		$1.51M Sell
1,643
-1,101
-40% -$1.12M 0.51% 39
2025
Q4 		$2.95M Buy
2,744
+1,411
+106% +$1.35M 0.79% 26
2025
Q3 		$1.02M Buy
1,333
+37
+3% +$27.5K 0.31% 42
2025
Q2 		$1.01M Buy
1,296
+61
+5% +$47.4K 0.36% 40
2025
Q1 		$1.02M Sell
1,235
-13
-1% -$10.8K 0.44% 35
2024
Q4 		$964K Buy
1,248
+68
+6% +$56.3K 0.63% 33
2024
Q3 		$1.05M Buy
1,180
+16
+1% +$14.4K 0.6% 37
2024
Q2 		$1.05M Buy
1,164
+31
+3% +$24.8K 0.53% 37
2024
Q1 		$881K Buy
1,133
+51
+5% +$36.3K 0.56% 40
2023
Q4 		$631K Buy
1,082
+145
+15% +$84.6K 0.45% 48
2023
Q3 		$503K Buy
937
+40
+4% +$20.6K 0.41% 58
2023
Q2 		$421K Buy
897
+54
+6% +$22.6K 0.29% 66
2023
Q1 		$289K Buy
843
+156
+23% +$52.6K 0.22% 90
2022
Q4 		$251K Buy
+687
New +$244K 0.2% 87

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

New Republic Capital's LLY Position: Q2 2026 in Review

New Republic Capital increased its Eli Lilly (LLY) stake by 83% in Q2 2026, buying an estimated $1.39M and bringing the position to 3,001 shares worth $3.6M. The position accounts for 0.83% of the portfolio, ranked #23.

New Republic Capital first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • New Republic Capital held 3,001 shares of Eli Lilly worth $3.6M as of Q2 2026.
  • New Republic Capital bought 1,358 Eli Lilly shares in Q2 2026, an estimated $1.39M.
  • Eli Lilly made up 0.83% of New Republic Capital's portfolio in Q2 2026, its #23 holding.
  • New Republic Capital first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on New Republic Capital's 13F filing for Q2 2026, filed 31 Jul 2026.